Abstract
OBJECTIVE
To compare embryo and birth data in cryopreserved-thawed blastocyst-stage ET cycles between natural endogenous hormone cycles and exogenous hormone stimulation cycles.
DESIGN
Retrospective cohort analysis.
SETTING
Large academic assisted reproductive technology center.
PATIENT(S)
One thousand three hundred ninety-one patient cycles undergoing frozen-thawed blastocyst-stage ET cycles.
MAIN OUTCOME MEASURE(S)
Live-birth rate.
INTERVENTION(S)
The synthetic protocol used GnRH agonist followed by estrogen and P. The natural protocol used monitoring and post-transfer P.
RESULT(S)
The patients in the two protocols had similar baseline characteristics. Multiple linear regression showed the synthetic protocol to have a higher live-birth rate (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.02-2.09). In patients having two embryos transferred, the synthetic stimulation protocol resulted in a higher live-birth rate per cycle start (32.3% vs. 20.4%; relative risk [RR], 1.58; 95% CI, 1.22-2.06). Similarly, patients with one or two embryos transferred who had additional cryopreserved blastocysts available also had a higher live-birth rate per cycle start (36.1% vs. 12.1; RR, 2.98; 95% CI, 1.16-7.63).
CONCLUSION(S)
The synthetic hormone protocol was associated with a higher live-birth rate when compared with a natural cycle protocol for frozen-thawed blastocyst-stage ET cycles. This improvement persisted when analysis was controlled for cycle cancellation. The synthetic stimulation protocol for frozen-thawed embryo cycles offers improved outcome results for patients.
TY - JOUR
T1 - A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles.
AU - Hill,Micah J,
AU - Miller,Kathleen A,
AU - Frattarelli,John L,
Y1 - 2009/01/26/
PY - 2008/03/03/received
PY - 2008/11/23/revised
PY - 2008/11/24/accepted
PY - 2009/1/28/entrez
PY - 2009/1/28/pubmed
PY - 2010/2/25/medline
SP - 416
EP - 22
JF - Fertility and sterility
JO - Fertil Steril
VL - 93
IS - 2
N2 - OBJECTIVE: To compare embryo and birth data in cryopreserved-thawed blastocyst-stage ET cycles between natural endogenous hormone cycles and exogenous hormone stimulation cycles. DESIGN: Retrospective cohort analysis. SETTING: Large academic assisted reproductive technology center. PATIENT(S): One thousand three hundred ninety-one patient cycles undergoing frozen-thawed blastocyst-stage ET cycles. MAIN OUTCOME MEASURE(S): Live-birth rate. INTERVENTION(S): The synthetic protocol used GnRH agonist followed by estrogen and P. The natural protocol used monitoring and post-transfer P. RESULT(S): The patients in the two protocols had similar baseline characteristics. Multiple linear regression showed the synthetic protocol to have a higher live-birth rate (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.02-2.09). In patients having two embryos transferred, the synthetic stimulation protocol resulted in a higher live-birth rate per cycle start (32.3% vs. 20.4%; relative risk [RR], 1.58; 95% CI, 1.22-2.06). Similarly, patients with one or two embryos transferred who had additional cryopreserved blastocysts available also had a higher live-birth rate per cycle start (36.1% vs. 12.1; RR, 2.98; 95% CI, 1.16-7.63). CONCLUSION(S): The synthetic hormone protocol was associated with a higher live-birth rate when compared with a natural cycle protocol for frozen-thawed blastocyst-stage ET cycles. This improvement persisted when analysis was controlled for cycle cancellation. The synthetic stimulation protocol for frozen-thawed embryo cycles offers improved outcome results for patients.
SN - 1556-5653
UR - https://www.unboundmedicine.com/medline/citation/19171338/A_GnRH_agonist_and_exogenous_hormone_stimulation_protocol_has_a_higher_live_birth_rate_than_a_natural_endogenous_hormone_protocol_for_frozen_thawed_blastocyst_stage_embryo_transfer_cycles:_an_analysis_of_1391_cycles_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(08)04639-6
DB - PRIME
DP - Unbound Medicine
ER -